Wajih, Nadeem
Erali, Richard A.
Forsythe, Steven D.
Schaaf, Cecilia R.
Shen, Perry
Levine, Edward A.
Soker, Shay
Morris, David L.
Votanopoulos, Konstantinos I.
Article History
First Online: 4 June 2024
Disclosure
: The authors declare no conflicts of interest except Dr. David Morris, who is CEO and co-founder of Mucpharm Pty Ltd, and provided bromelain materials and additional financial support for this work. Dr. Konstantinos Votanopoulos declares Organoid released patents.